āagman

Not investment advice. Data and computed figures, for information only.

India Glycols Ltd

NSE: INDIAGLYCO
₹331.95
+₹3.40 (+1.03%)
NSE · 16 Oct 2026, close
NSE
As of 31 Mar 2026
Market Cap
₹2,209 Cr
CMP
₹331.95
52-wk High / Low
₹1,222 / 245
P/E
7.0
P/B
0.8
Book Value
₹438.0
Div Yield
2.28%
ROCE
12.0%
ROE
11.3%
Face Value
₹5
D/E
0.58

Price−60.3% over 1Y

āagman read

Computed by āagman
Derived from 12 years and 13 quarters of filings. Not reported by the company.
As of 16 Oct 2026
How we compute these
Piotroski F-Score
7
/ 9
7 of 9 F-score tests passed
Graham Number
₹656
√(22.5 × EPS × book value per share)
ROIC
8.3%
vs 13.1% sector median
Cash flow to profit
2.62
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
+62
bps OPM YoY
Operating margin vs the same quarter last year
Sustainable growth
9.5%
ROE × earnings retention ratio
ROE stability
4.1
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom +0.00FII −0.03DII +0.02
Latest quarter vs the previous one
Cash-accrual divergence
−7.5%
of assets
Low = accruals track cash flow
Strengths
+FII holding rose by 1.1pp over the last year
+Piotroski F-Score of 7/9 is in the strong band (≥7)
+PE of 7.0x is below the sector median of 34.6x
Watch-outs
−Latest ROCE of 12% trails the sector median of 19%
−Borrowings are up 36.8% since FY2016 (1236 to 1691)
−Price trades below its 200-day moving average (0.4x)
−Price is 72.8% below its 52-week high
−Annualised volatility of 157.2% is in the high band (≥45%)
−Promoter holding fell by 1.4pp over the last year

Peer comparison

Peers
NameP/EMar Cap ₹ CrROCE %ROE %

Quarterly results

Consolidated basis (as filed) · ₹ Cr · 13 quarters
As of 30 Jun 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales6897759049269699619758631,0401,0921,1029761,130
Expenses589679802822843845852717891935927810961
Operating Profit10096102105126116124146150158175166170
OPM %14.5%12.4%11.3%11.3%13.0%12.1%12.7%16.9%14.4%14.5%15.9%17.0%15.0%
Other Income121291014151913201431421
Interest28293133364044454549472625
Depreciation21282626282827333438414142
Profit before tax6450545676637182918491112123
Net Profit51384242605057647365688797
EPS (₹)8.256.136.716.819.748.029.1610.3311.8110.5110.0912.9714.45

Profit & Loss

As of 30 Jun 2026
Consolidated · ₹ Cr · 12 years + TTM
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales2,5792,3242,5003,0343,3572,7352,3172,8682,6513,2943,7684,2114,301
Expenses2,4552,1492,2632,7122,9412,4332,0262,5992,3462,8793,2573,5623,632
Operating Profit124175237322416303291269305415511649669
OPM %4.8%7.5%9.5%10.6%12.4%11.1%12.6%9.4%11.5%12.6%13.6%15.4%15.6%
Other Income−16−477231724152605430615051
Interest163139127125143978370100121164167148
Depreciation896972737678808094101115155163
Profit before tax−144−8145147213153143379165223292377410
Net Profit−89−573597133115132340141173231293316
EPS (₹)−14.30−9.165.6515.5721.3918.4921.2354.8120.1727.9037.2543.7048.02

Balance Sheet

As of 30 Jun 2026
Consolidated · ₹ Cr
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Jun 2026
Equity Capital313131313131313131313134—
Reserves2666877218149321,0031,1381,7611,8702,0202,2252,899—
Borrowings2,2641,2361,0958341,0009991,1371,0471,1121,3481,8921,691—
Other Liabilities5931,6651,6451,7421,8212,0531,8141,7921,8452,2182,0291,900—
Total Liabilities3,1543,6203,4923,4213,7844,0864,1194,6314,8585,6176,1766,523—
Fixed Assets1,1462,0292,1112,1562,1732,2282,1932,3182,7173,2053,8294,554—
CWIP1621819189137172126243125849837—
Investments4282524212627336318335381389—
Other Assets1,8431,3821,2651,1521,4531,6601,7741,7341,6981,9931,8671,543—
Total Assets3,1543,6203,4923,4213,7844,0864,1194,6314,8585,6176,1766,523—

Cash Flows

As of 31 Mar 2026
Consolidated · ₹ Cr
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity−1711,231302502147343137116326439362769
Cash from Investing Activity175−78−40−103−128−151−14876−330−503−736−767
Cash from Financing Activity−4−1,168−263−3993−21611−189−19035423
Net Cash Flow0−15−1022−2304−525−2025

Ratios

As of 31 Mar 2026
12 periods
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %3.05.09.015.020.014.010.09.08.011.012.012.0
ROE %———————————11.3
EPS (₹)−14.30−9.165.6515.5721.3918.4921.2354.8120.1727.9037.2543.70
Book Value (₹)———————————438.0
Face Value (₹)———————————5
P/E———————————7.0
Div Yield %———————————2.28
NPM %−3.5−2.51.43.23.94.25.710.95.25.26.06.9
OPM %4.88.09.011.012.011.013.09.012.013.014.015.0
D/E7.621.721.460.991.040.970.970.580.580.660.840.58
P/B———————————0.8

Growth

As of 11 Oct 2026
Compounded sales growth
10 years+6.0%
5 years+13.0%
3 years+17.0%
TTM+12.0%
Compounded profit growth
10 years+74.0%
5 years+14.0%
3 years+39.0%
TTM+30.0%
Stock price CAGR
10 years+38.0%
5 years+27.0%
3 years+64.0%
Last year+66.0%
Return on equity
10 years10.0%
5 years10.0%
3 years10.0%
Last year11.0%

Shareholding pattern

As of 31 Mar 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters61.07%61.07%61.01%61.01%61.01%61.01%61.01%61.02%61.02%61.02%59.63%59.63%
FIIs0.00%0.00%2.42%3.00%1.85%1.30%2.18%1.17%1.80%2.24%2.27%2.24%
DIIs2.14%2.14%0.70%0.57%0.13%0.26%4.61%4.17%0.08%0.91%5.19%5.21%
Government————————————
Public36.80%36.80%35.86%35.41%37.01%37.43%32.19%33.64%37.11%35.82%32.91%32.91%
No. of shareholders30,29330,29330,85435,82834,49634,58843,32942,86959,57959,73652,84852,968
Change since Jun 2023 (pp)
Promoters −1.44FIIs +2.24DIIs +3.07Public −3.89

Documents

As of 11 Oct 2026
Announcements
Intimation Of GST OrderClarification On Movement In PriceClarification sought from India Glycols LtdApportionment Of Cost Of Acquisition Of Equity Shares Of India Glycols Limited ('Demerged Company'/'The Company'), Ennature Bio Pharma Limited ('Resulting Company 1') And IGL Spirits Limited ('Resulting Company 2') Pursuant To Scheme Of Arrangement Amongst The Company, Resulting Company 1 And Resulting Company 2 And Their Respective Shareholders ('Scheme'/'Scheme Of Arrangement')Update On Analyst / Institutional Investor Meetings.
Annual reports
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022
Credit ratings
Rating updateRating updateRating updateRating updateRating update
Concalls
Sep 2026PPTSep 2026PPTSep 2026PPTSep 2026TranscriptSep 2026PPTSep 2026RecordingAug 2026PPT

Corporate actions

As of 2 Sep 2026
2 Sep 2026DEMERGERDemerger—
23 Mar 2026DIVIDENDInterim Dividend - Rs 7.50 Per Share—
23 Sep 2025DIVIDENDDividend - Rs 5 Per Share—
12 Aug 2025SPLITFace Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 5/- Per Share10 : 5
21 Aug 2024DIVIDENDAnnual General Meeting/Dividend - Rs 8 Per Share—
5 Sep 2023DIVIDENDAnnual General Meeting/Dividend - Rs 7.50 Per Share—
29 Aug 2022DIVIDENDAnnual General Meeting/Dividend - Rs 7.50 Per Share—
16 Sep 2021DIVIDEND Annual General Meeting/Dividend - Rs 6 Per Share—
11 Mar 2020DIVIDEND Interim Dividend - Rs 6 Per Share—
13 Aug 2019DIVIDEND Annual General Meeting/Dividend - Rs 6 Per Share—
26 Jul 2018DIVIDEND Annual General Meeting/Dividend- Rs 4 Per Share—
23 Aug 2017DIVIDEND Annual General Meeting/Dividend - Re 1/- Per Share—
8 Sep 2014DIVIDENDAnnual General Meeting / Final Dividend - Re 1/- Per Share—
5 Sep 2013DIVIDENDAnnual General Meeting / Final Dividend - Rs 2/- Per Share—
14 Mar 2013DIVIDENDInterim Dividend Rs 4 Per Share—
3 Sep 2012DIVIDENDAnnual General Meeting/Dividend Rs 3 Per Share—
13 Sep 2011DIVIDENDAnnual General Meeting/Dividend Rs 1.50 Per Share—
6 Aug 2010DIVIDENDAnnual General Meeting / Dividend Rs 1.50 Per Share—
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman